$2.79 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 103 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARLZ | Exit | ARALEZ PHARMACEUTICALS INC | $0 | – | -1,644,583 | -100.0% | -0.02% | – |
| NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -233,332 | -100.0% | -0.05% | – |
| XNCR | Exit | XENCOR INC | $0 | – | -48,366 | -100.0% | -0.06% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -1,458,537 | -100.0% | -0.10% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -125,000 | -100.0% | -0.12% | – |
| STDY | Exit | STEADYMED LTD | $0 | – | -918,120 | -100.0% | -0.14% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -1,764,889 | -100.0% | -0.18% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -200,000 | -100.0% | -0.20% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -179,381 | -100.0% | -0.22% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -178,806 | -100.0% | -0.24% | – |
| ECOR | Exit | ELECTROCORE INC | $0 | – | -425,000 | -100.0% | -0.25% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -650,000 | -100.0% | -0.29% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -349,539 | -100.0% | -0.32% | – |
| IVTY | Exit | INVUITY INC | $0 | – | -2,336,889 | -100.0% | -0.32% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -628,262 | -100.0% | -0.32% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -600,000 | -100.0% | -0.34% | – |
| Exit | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $0 | – | -16,600,000 | -100.0% | -0.38% | – | |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -146,000 | -100.0% | -0.50% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -165,175 | -100.0% | -0.55% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -168,000 | -100.0% | -0.58% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -398,194 | -100.0% | -0.61% | – |
| Exit | RADIUS HEALTH INCnote 3.000% 9/0 | $0 | – | -21,000,000 | -100.0% | -0.68% | – | |
| NTRA | Exit | NATERA INC | $0 | – | -1,080,829 | -100.0% | -0.71% | – |
| Exit | DEPOMED INCnote 2.500% 9/0 | $0 | – | -27,019,000 | -100.0% | -0.77% | – | |
| LCI | Exit | LANNET INC | $0 | – | -1,801,353 | -100.0% | -0.86% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -531,000 | -100.0% | -1.12% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -550,000 | -100.0% | -1.24% | – |
| Exit | TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $0 | – | -43,000,000 | -100.0% | -1.24% | – | |
| Exit | ENDOLOGIX INCnote 3.250%11/0 | $0 | – | -40,500,000 | -100.0% | -1.34% | – | |
| AET | Exit | AETNA INC NEW | $0 | – | -229,000 | -100.0% | -1.48% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -6,988,248 | -100.0% | -4.58% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.